SINTX Technologies, Inc. earnings releases SINT

SINTX Technologies, Inc. last reported quarterly results on Oct 1, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $2.2 million (+952.9% year over year) and diluted EPS of -$0.24. It usually reports 1–45 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 12, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 1–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 1, 2026
1 days after quarter end
Q3 FY2026
ended Sep 30, 2026
2
+952.9%
-2
+54.9%
-0.24
+93.1%
Aug 11, 2026
42 days after quarter end
Q2 FY2026
ended Jun 30, 2026
0
+199.3%
-3
-16.7%
-0.75
+17.6%
Nov 13, 2025
44 days after quarter end
Q3 FY2025
ended Sep 30, 2025
0
-74.0%
-4
+43.3%
-3.46
+50.3%
May 15, 2025
45 days after quarter end
Q1 FY2025
ended Mar 31, 2025
0
-46.3%
-2
-158.7%
-1.29
+94.0%
Jan 23, 2024
23 days after quarter end
—
ended Dec 31, 2023
—
—
—
Jan 25, 2023
25 days after quarter end
—
ended Dec 31, 2022
—
—
—
Nov 10, 2016
41 days after quarter end
—
ended Sep 30, 2016
—
—
—
Aug 11, 2016
42 days after quarter end
—
ended Jun 30, 2016
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SINT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1269026
Former names
AMEDICA CORP (until Oct 5, 2018); AMEDICA Corp (until Oct 5, 2018)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.